Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-09

Clinical Trial Update: Treating Postictal Symptoms Using Ibuprofen and Nifedipine [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by the University of Calgary is evaluating the combination of ibuprofen and nifedipine to treat postictal symptoms in epileps…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)
  • Nifedipine (nifedipine)

Snippet

Sponsor: University of Calgary | Conditions: Epilepsy, Epilepsies, Partial | Phase 2 | Status: RECRUITING